Reconsidering dopaminergic modulation in Alzheimer's disease: A case for levodopa/carbidopa as a disease‐modifying agent

ABSTRACT:

SUBMITTER: Nobili A 

PROVIDER: S-EPMC12284314 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature